Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KB.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.51.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.51.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.51.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.51.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDD.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDD.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDD.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.526 (Iota)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.526 (Iota)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.526 (Iota)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.526 (Iota)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.2 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.2 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.621 (Mu)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.621 (Mu)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.621 (Mu)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.621 (Mu)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.9.2 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.9.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.9.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.9.2 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.34 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.34 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.34 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.34 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.47 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.47 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.47 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.47 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
P.1.17 (Gamma)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
P.1.17 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.17 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.17 (Gamma)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.126 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used